Department of Obstetrics and Gynecology.
Division of Gynecologic Oncology.
Am J Clin Oncol. 2020 Feb;43(2):122-127. doi: 10.1097/COC.0000000000000643.
The objective of this study is to assess the reliability of intraoperative uterine assessment compared with the final pathologic evaluation in patients with endometrial cancer (EC) and whether assessment improves with experience.
After Institutional Review Board approval, a prospective cohort study of women surgically managed with biopsy-proven complex atypical hyperplasia (CAH) or EC between March 2015 and December 2016 was performed. Demographics, preoperative biopsy results, procedure, intraoperative and final pathologic evaluation of lesion size, myometrial invasion, and lower uterine segment/cervical involvement were abstracted. The agreement between the intraoperative and final pathologic evaluation of tumor involvement of the uterus was determined using the kappa statistic and the intraclass correlation coefficient.
A total of 264 patients with a preoperative diagnosis of CAH or EC were included-71 (26.9%) with CAH and 193 (73.1%) with EC. The mean age was 62.6±11.5, and mean body mass index was 37.2±10.1. The majority of women were white (67%). A total of 227 (85.9%) patients underwent a laparoscopic or robotic hysterectomy, whereas 36 (13.6%) underwent an abdominal hysterectomy. 233 (88.3%) patients had EC and 21 (7.9%) patients had CAH on final pathology. There was a fair agreement between the intraoperative estimation of myometrial invasion (κ=0.37). A moderate agreement exists between the intraoperative estimation of lower uterine segment/cervical involvement (κ=0.57). There was a strong agreement between intraoperative tumor size assessment and the final path (intraclass correlation coefficient=0.74). The intraoperative correlation of tumor size was similar for the first half of the cohort (κ=0.50) and the second half (κ=0.46) chronologically.
Despite only a fair correlation in the myometrial invasion, intraoperative assessment of cervical involvement and especially tumor size is more readily identified and overall accurate. Therefore, intraoperative evaluation is an additional tool to use when making the decision to proceed with surgical staging.
本研究旨在评估子宫内膜癌(EC)患者术中子宫评估与最终病理评估的可靠性,以及评估是否随着经验的增加而改善。
在获得机构审查委员会批准后,对 2015 年 3 月至 2016 年 12 月期间接受经活检证实为复杂不典型增生(CAH)或 EC 手术治疗的女性进行了一项前瞻性队列研究。提取患者的人口统计学资料、术前活检结果、手术过程、术中及最终病理评估的病变大小、肌层浸润程度、子宫下段/宫颈受累情况。采用κ统计量和组内相关系数(intraclass correlation coefficient,ICC)确定术中与最终病理评估肿瘤子宫受累情况的一致性。
共纳入 264 例术前诊断为 CAH 或 EC 的患者,其中 71 例(26.9%)为 CAH,193 例(73.1%)为 EC。患者的平均年龄为 62.6±11.5 岁,平均 BMI 为 37.2±10.1。大多数患者为白人(67%)。227 例(85.9%)患者行腹腔镜或机器人辅助子宫切除术,36 例(13.6%)行腹式子宫切除术。233 例(88.3%)患者最终病理诊断为 EC,21 例(7.9%)患者为 CAH。术中估计肌层浸润程度的一致性一般(κ=0.37)。术中估计子宫下段/宫颈受累程度的一致性中等(κ=0.57)。术中肿瘤大小评估与最终病理结果的一致性较强(ICC=0.74)。术中肿瘤大小的相关性在队列前半部分(κ=0.50)和后半部分(κ=0.46)时间上相似。
尽管肌层浸润程度的相关性仅为中等,但宫颈受累程度,尤其是肿瘤大小的术中评估更容易识别且总体准确。因此,术中评估是在决定是否进行手术分期时可额外使用的一种工具。